Welcome to our dedicated page for AirSculpt Technologies news (Ticker: AIRS), a resource for investors and traders seeking the latest updates and insights on AirSculpt Technologies stock.
AirSculpt Technologies, Inc. provides premium body contouring procedures through AirSculpt offices. Its AirSculpt method is a minimally invasive treatment for fat removal, skin tightening, targeted body sculpting, and fat transfer procedures that use a patient’s own fat cells.
Company news centers on operating results, same-center and same-store sales trends, case volume, revenue, adjusted EBITDA, guidance, marketing initiatives, new procedure categories, balance sheet activity, and governance changes. Updates also address the company’s positioning within aesthetics demand tied to GLP-1 use and its direct medical procedure services model.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
AirSculpt Technologies (NASDAQ: AIRS) has expanded its operations with the opening of two new centers in Austin, Texas, and Orange County, California, bringing its total to 24 locations across the U.S. and Canada. The new centers aim to meet the increasing demand for AirSculpt's patented body contouring procedures, which are known for their minimal invasiveness and quick recovery times. Over 40,000 procedures have already been performed, indicating a strong market presence. CEO Todd Magazine expressed enthusiasm about the expansion, highlighting the growing consumer interest in their premium services.
AirSculpt Technologies, Inc. (NASDAQ:AIRS) announced its fourth quarter and full year 2022 results, highlighting significant growth in case volume and revenue.
Fourth quarter case volume increased by 15.7% year-over-year, reaching 3,337, while revenue rose by 8.4% to $40.7 million. For the full year, case volume grew 18.2% to 13,063 and revenue surged 26.6% to $168.8 million. Despite a diluted loss per share of $(0.26), the company reported an adjusted net income of $0.37 per share. Looking ahead, AirSculpt expects revenues between $187 million and $192 million for 2023, driven by the opening of five new centers.
AirSculpt Technologies, Inc. (NASDAQ: AIRS) will report its fourth quarter 2022 financial results on March 10, 2023, before market open. A conference call is scheduled for 8:30 a.m. Eastern Time on the same day, accessible via phone or a live webcast on the company’s investor relations website. AirSculpt is a leading provider of body contouring procedures utilizing its proprietary AirSculpt® method, offering a premium consumer experience through minimally invasive fat removal. The company aims to deliver exceptional results to its patients, reflecting its commitment to quality care.